Related Experiment Video
Updated: Jul 8, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Vascular versus myocardial dysfunction in acute coronary syndrome: are the adhesion molecules as powerful as
Peter A Kavsak1, Dennis T Ko, Alice M Newman
1Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada. kavsakp@mcmaster.ca
Insights
Early elevations of N-terminal pro-B-type natriuretic peptide (NT-proBNP) predict adverse outcomes in acute coronary syndrome (ACS). However, adhesion molecules measured early after pain onset do not aid in long-term risk stratification for ACS patients.
Area of Science:
- Cardiology
- Biomarker Research
- Acute Coronary Syndromes
Background:
- Acute coronary syndrome (ACS) poses a significant risk for mortality and myocardial infarction.
- Effective risk stratification is crucial for managing ACS patients and optimizing treatment strategies.
- Adhesion molecules and NT-proBNP are potential biomarkers for cardiovascular risk assessment.
Purpose of the Study:
- To evaluate the utility of adhesion molecules and NT-proBNP in risk stratification for ACS patients.
- To determine if early elevations of these biomarkers predict future adverse cardiovascular events.
Main Methods:
- A cohort of 216 ACS patients was analyzed.
- Measurements included a cell adhesion array and NT-proBNP levels.
- Statistical analyses employed Kaplan-Meier and Cox models.
Main Results:
- Early elevations of NT-proBNP were found to be predictive of future death or myocardial infarction.
- Adhesion molecule levels measured early after pain onset did not show predictive value for these outcomes.
- NT-proBNP demonstrated utility in risk stratification, unlike the assessed adhesion molecules.
Conclusions:
- Adhesion molecules measured early in the course of ACS are not useful for long-term risk stratification.
- NT-proBNP is a valuable early predictor of adverse events in ACS.
- Further research may explore other roles or specific adhesion molecules in ACS management.
Objectives:
To determine if elevations of adhesion molecules in acute coronary syndrome (ACS) are useful for risk stratification.
Design And Methods:
A cell adhesion array (Randox Ltd.) and NT-proBNP were measured in 216 ACS patients.
Results:
Kaplan-Meier and Cox models indicate early elevations of NT-proBNP but not the adhesion molecules are predictive of future death/myocardial infarction.
Discussion:
Elevations of adhesion molecules early after pain onset in ACS are not useful for long-term risk stratification.
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome I: Introduction
Myocarditis I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
